Halstead Michael
- SEC CIK
- 0001521548
In the past year, 1 open-market purchase filing worth $1.35M and no sales.
Current role at each company
- HELP Cybin Inc.Chief Executive Officeras of Sep 21, 2026
- ITCI Intra-Cellular Therapies, Inc.Presidentas of Apr 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $1.35M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$1.35M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Halstead Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
HELP Cybin Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 (view filing)5:07 PM ET | Sep 21 | Same day | Halstead MichaelChief Executive Officer | PPurchase | +100.0K | $13.47 | +$1.35M | +145.8%168.6K after |
ITCI Intra-Cellular Therapies, Inc.
President14 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2021 (view filing) | Dec 21 | 2 days | Halstead MichaelEVP and General Counsel | SSale | −176.9K | $47.56 | −$8.41M | −100.0%0 after | 5 lots |
| Jan 11, 2022 (view filing) | Jan 10 | 1 day | Halstead MichaelEVP and General Counsel | SSale | −19.6K | $40.77 | −$800.8K | −100.0%0 after | 3 lots |
| Feb 23, 2022 (view filing) | Feb 22 | 1 day | Halstead MichaelEVP and General Counsel | SSale | −11.1K | $55.40 | −$617.1K | −100.0%0 after | 2 lots |
| Feb 25, 2022 (view filing) | Feb 24 | 1 day | Halstead MichaelEVP and General Counsel | SSale | −7.91K | $51.98 | −$410.9K | −100.0%0 after | 2 lots |
| Dec 2, 2022 (view filing) | Dec 1 | 1 day | Halstead MichaelEVP and General Counsel | SSale | −50.0K | $53.73 | −$2.69M | −100.0%0 after | 2 lots |
| Feb 22, 2023 (view filing) | Feb 21 | 1 day | Halstead MichaelEVP and General Counsel | SSale | −11.1K | $46.84 | −$521.7K | −100.0%0 after | 4 lots |
| Feb 27, 2023 (view filing) | Feb 24 | 3 days | Halstead MichaelEVP and General Counsel | SSale | −7.91K | $47.03 | −$371.8K | −100.0%0 after | |
| Mar 13, 2023 (view filing) | Mar 10-13 | 3 days | Halstead MichaelEVP and General Counsel | SSale | −24.1K | $43.66 | −$1.05M | −100.0%0 after | 4 lots |
| Nov 14, 2023 (view filing) | Nov 13 | 1 day | Halstead MichaelEVP and General Counsel | SSale | −50.0K | $53.90 | −$2.69M | −100.0%0 after | 2 lots10b5-1 |
| Jan 12, 2024 (view filing) | Jan 11 | 1 day | Halstead MichaelEVP and General Counsel | SSale | −50.0K | $66.83 | −$3.34M | −100.0%0 after | 3 lots10b5-1 |